Showing 1241-1250 of 2182 results for "".
- Allergan Aesthetics Expands Training Network with New AMI Center in Austinhttps://modernaesthetics.com/news/allergan-aesthetics-expands-training-network-with-new-ami-center-in-austin/2486599/Allergan Aesthetics, an AbbVie company, has announced the opening of a new Allergan Medical Institute (AMI) training center in Austin, Texas, expanding its US educational footprint for aesthetic providers. The facility represents the third AMI Training Center launched in the within the past year,
- Revision Skincare Announces 2 Studies Evaluating 30% THD Ascorbate Serum for Skin Quality Outcomeshttps://modernaesthetics.com/news/revision-skincare-announces-2-studies-evaluating-30-thd-ascorbate-serum-for-skin-quality-outcomes/2486573/Two peer-reviewed studies published in the Journal of Cosmetic Dermatology evaluated the cosmetic efficacy and tolerability of a high-strength vitamin C formulation containing 30% tetrahexyldecyl ascorbate (THD ascorbate) (C+ Correcting Complex 30%; Revision Skincare), Revision Skincare<
- Systematic Review Examines Vaginal Laser and Radiofrequency for Stress Urinary Incontinencehttps://modernaesthetics.com/news/systematic-review-examines-vaginal-laser-and-radiofrequency-for-stress-urinary-incontinence/2486518/In a systematic review and meta-analysis published in International Urogynecology Journal, investigators reported that energy-based devices may offer modest short-term symptom improvement for women with stress urinary incontinence compared with sham treatment. David Lukanović, Gee
- GPX4 Modulator Shows Early Promise in First-in-Human Studyhttps://modernaesthetics.com/news/gpx4-modulator-shows-early-promise-in-first-in-human-study/2486474/A novel topical therapy targeting cellular senescence showed early biologic activity across multiple dermatologic conditions in a Phase 1 clinical trial, according to data presented by Frederick Beddingfield III, MD, PhD, FAAD, at the Dermatology Innovation Forum during the American Academy of De
- Study Supports Safety, Efficacy of Subcutaneous Forehead Lift for Upper Facial Aginghttps://modernaesthetics.com/news/study-supports-safety-efficacy-of-subcutaneous-forehead-lift-for-upper-facial-aging/2486458/A retrospective analysis published in Frontiers in Surgery evaluated the effectiveness and safety of subcutaneous forehead lift (SFL) for reducing horizontal forehead and glabellar wrinkles using the validated Wrinkle Assessment Scale (WAS). The study included 697 patients treated at a s
- AAD 2026: RelabotulinumtoxinA Shows Consistent Efficacy Across Age Groupshttps://modernaesthetics.com/news/aad-2026-relabotulinumtoxina-shows-consistent-efficacy-across-age-groups/2486431/A post hoc analysis presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, evaluated the impact of age on outcomes with relabotulinumtoxinA in patients with moderate-to-severe glabellar lines (GLs) and lateral canthal lines (LCLs). The analysis pooled data
- AAD 2026: Revance to Showcase Expanding Aesthetics Portfoliohttps://modernaesthetics.com/news/aad-2026-revance-to-showcase-expanding-aesthetics-portfolio/2486383/Revance Therapeutics Inc. announced it will showcase its expanding portfolio of aesthetics, regenerative medicine, and consumer skincare products at the 2026 American Academy of Dermatology (AAD) Annual Meeting, scheduled for March 26–31 in Denver, Colorado. The company plans a series of in-booth
- AAD 2026: Acclaro to Highlight Expanding Clinical Uses of UltraClear 2910 nm Fiber Laserhttps://modernaesthetics.com/news/aad-2026-acclaro-to-highlight-expanding-clinical-uses-of-ultraclear-2910-nm-fiber-laser/2486381/Emerging clinical data on Acclaro’s UltraClear® 2910 nm fiber laser is set to be presented during multiple sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado from March 26 through 31. The technology, a cold ablative fiber lase
- Survey: 53% of Americans Would Sacrifice Everyday Spending for Aesthetic Treatmentshttps://modernaesthetics.com/news/survey-53-of-americans-would-sacrifice-everyday-spending-for-aesthetic-treatments/2486047/More than half of Americans say they would sacrifice everyday spending to afford non-surgical aesthetic procedures, according to a new national survey commissioned by LaserAway and conducted by Morning Consult among 2,202 US adults in February 2026. The findings highlight shifting consumer attitu
- Adipocytes Emerge as Central Drivers of Skin Aging in New Reviewhttps://modernaesthetics.com/news/adipocytes-emerge-as-central-drivers-of-skin-aging-in-new-review/2485879/A recent review in Biogerontology reframes skin aging by positioning adipocytes—particularly dermal white adipose tissue (dWAT)—as central regulators of age-related cutaneous change. Traditionally, skin aging has been attributed to epidermal and dermal alterations, including keratinocyte